Abstract:Objective: To screen differential proteins associated with recurrence from tumor tissue in patients undergoing liver transplantation for hepatocellular carcinoma (HCC), and to supply the research basis for searching more sensitive and specific biomarkers involved in predicting prognosis. Methods: A cohort of tumor samples were obtained from 19 patients meeting the "Shanghai criteria". Among them, 6 samples were selected from recurrence group and 13 from disease free survival (DFS) group. The protein spectra of tumor cells were created by surface enhanced laser desorption/ionization-time of flight-mass spectroscopy (SELDI-TOF-MS), and the intensity values for each peak were analyzed by Biomarker Wizard Software to screen recurrence-associated biomarkers. Results: According to protein fingerprints determined by weak cation exchange (WCX2) chip measurement, a total of 163 protein peaks were identified at the mass to charge (m/z) value ranging from 2000 to 30000. Six proteins were significantly associated with recurrence when compared with controls (P<0.05). Four proteins were up-regulated with the m/z value of 2129, 2203, 2950 and 3 062, and two proteins were down-regulated with the m/z value of 3708 and 11 856 in recurrence group. Conclusions: These differential proteins may play key roles in predicting the prognosis of the patients undergoing liver transplantation for HCC, which may also correspond with the existence of microscopic vascular invasion.

Screening of recurrence-associated biomarkers from tumor tissue in patients undergoing liver transplantation for hepatocellular carcinoma (HCC)